S12X WITH ESAX OPTION— 510(k) K082629

Substantially Equivalent

Chatten Associates, Inc.

FDA 510(k) clearance K082629 for S12X WITH ESAX OPTION, Substantially Equivalent on 2009-07-01. Applicant: Chatten Associates, Inc..

Clearance details

Applicant: Chatten Associates, Inc.
Product code: Code GYC
Advisory panel: Neurology
Date received: 2008-09-09
Decision date: 2009-07-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: West Conshohocken, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.